Clinical Trials for Acrotech Biopharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Acrotech Biopharma

Clinical Trials (4)

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

PHASE3Recruiting

504 participants

Started: Oct 4, 2023 · Completed: Nov 30, 2030

1 condition1 sponsor69 locations

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

PHASE1Recruiting

24 participants

Started: Dec 28, 2022 · Completed: Sep 30, 2027

2 conditions1 sponsor2 locations

Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

PHASE2Active, not recruiting

Started: Dec 15, 2021 · Completed: Jan 31, 2028

1 condition3 sponsors1 location

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

PHASE1Recruiting

34 participants

Started: May 3, 2021 · Completed: Aug 31, 2026

2 conditions3 sponsors2 locations